secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAPTYSBIO, INC (ANAB)
CIK:        0001370053
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0001370053-24-000029
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AnaptysBio shareholders elect three Class I directors and approve equity plan amendment at 2024 annual meeting
--------------------------------------------------------------------------------

- Daniel Faga, Dennis Fenton, and Oleg Nodelman elected as Class I directors with 22.3M, 21.9M, and 18.8M votes for, respectively.
- Ratification of KPMG as independent auditor for FY 2024 approved with 24.7M shares for, 30k against.
- Non-binding advisory vote on executive compensation passed with 19.9M for, 2.95M against.
- Amendment and restatement of 2017 Equity Incentive Plan approved with 16.8M for, 4.7M against, 1.3M abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1370053/000137005324000029/0001370053-24-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1370053/000137005324000029/anab-20240612.htm
  HTML page:      https://secwatch.observer/filing/0001370053-24-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer